CatalYm
Marianne Uteng - Observer
Oncology
Munich, Germany
CatalYm is developing innovative immunotherapies to transform the tumor microenvironment and substantially improve treatment options for cancer patients.
It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.